- cross-posted to:
- hackernews@lemmy.bestiver.se
- cross-posted to:
- hackernews@lemmy.bestiver.se
Pharma manufacturer Gilead making available at cost (2 million doses in most needed countries) while generics are developed and can later be distributed. Decent play from a Pharma company.
As am I, but don’t stop counting yet. I’m sure this administration will guarantee many more are lost.
I am glad that it’s going to countries with the most need first. Lessens the chance of being wasted or withheld.